These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22212564)

  • 61. Hepatitis C virus eradication in the elderly: The challenge worth a long-life elixir?
    Vukotic R; Conti F; Andreone P
    J Hepatol; 2017 Mar; 66(3):476-477. PubMed ID: 28012863
    [No Abstract]   [Full Text] [Related]  

  • 62. [Elimination of hepatitis C virus infection].
    Pol S
    Presse Med; 2019 Jan; 48(1 Pt 1):1-3. PubMed ID: 30784420
    [No Abstract]   [Full Text] [Related]  

  • 63. A US plan for HCV elimination.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):1. PubMed ID: 36495899
    [No Abstract]   [Full Text] [Related]  

  • 64. When prevention fails. Towards more efficient strategies for plant disease eradication.
    Vicent A; Blasco J
    New Phytol; 2017 May; 214(3):905-908. PubMed ID: 28397360
    [No Abstract]   [Full Text] [Related]  

  • 65. Trial watch: Protease inhibitors show promise against HCV.
    Nat Rev Drug Discov; 2009 Jan; 8(1):11. PubMed ID: 19116621
    [No Abstract]   [Full Text] [Related]  

  • 66. Boceprevir.
    Maddur H; Kwo PY
    Hepatology; 2011 Dec; 54(6):2254-7. PubMed ID: 22095684
    [No Abstract]   [Full Text] [Related]  

  • 67. [Studies with boceprevir].
    MMW Fortschr Med; 2011 Jul; 153(29-31):16. PubMed ID: 21830728
    [No Abstract]   [Full Text] [Related]  

  • 68. Editorial: Towards the eradication of hepatitis C virus.
    Marcellin P; Asselah T
    Liver Int; 2012 Feb; 32 Suppl 1():1. PubMed ID: 22212564
    [No Abstract]   [Full Text] [Related]  

  • 69. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M; Timm J
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Telaprevir: a new hope in the treatment of chronic hepatitis C?
    Fowell AJ; Nash KL
    Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?
    Halfon P; Sarrazin C
    Liver Int; 2012 Feb; 32 Suppl 1():79-87. PubMed ID: 22212577
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Hepatitis C: therapeutic perspectives].
    Trépo C
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B297-302. PubMed ID: 12180304
    [No Abstract]   [Full Text] [Related]  

  • 73. Future of hepatitis C therapy: development of direct-acting antivirals.
    Dore GJ; Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.